Australia Hospital Supplies Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

Market Overview

The Australia hospital supplies market is growing steadily as hospitals treat more patients and governments pay closer attention to supply security. Demand is led by public hospitals, yet private operators, day surgery centres and procurement bodies are reshaping who buys, from whom and at what price.

Three forces are at work: record state health budgets, with Queensland setting aside AUD 35.5 billion in June 2026 and Victoria AUD 32.3 billion in May 2026; sovereign supply policy for critical items such as intravenous fluids; and tighter procurement discipline, since Victoria's auditor found in June 2025 that off-contract spending was not effectively tracked.

In March 2025 the federal health minister announced a AUD 40 million Baxter expansion at Toongabbie. In late September 2026 the sale of Healthscope's remaining hospitals to new owners was announced, and in October 2026 the Australian Institute of Health and Welfare reported hospital spending above AUD 123 billion.

Key Market Trends and Insights

• Large hospital spending base: The Australian Institute of Health and Welfare reported in October 2026 that hospital spending topped AUD 123 billion, which anchors recurring demand for disposables.
• Record state budgets: Queensland committed AUD 35.5 billion to health in June 2026, including more than 2,600 additional beds that will all need consumables.
• Sovereign supply push: Baxter's AUD 40 million expansion, announced in March 2025, lifts intravenous fluid capacity to 80 million units a year against national demand of about 60 million units.
• Procurement scrutiny: Victoria's auditor-general reported in June 2025 that 72 collective agreements covered 1,086 supplier agreements, yet off-contract spending was not effectively tracked.

Australia Hospital Supplies Market Size and Forecast

The market is moving from price-led purchasing towards supply-secure, contract-compliant buying across public and private hospitals. Surgical and procedural disposables lead in value because every theatre list consumes them, while syringes, needles and intravenous therapy products advance fastest as local fluid capacity expands. Public hospitals remain the largest buyers, and day surgery and specialty clinics gain share as elective surgery programs scale up. Government group purchasing contracts anchor volume, with direct manufacturer relationships growing as hospitals seek resilience. New South Wales remains the largest region, and Queensland grows quickest on its hospital building program. Sovereign manufacturing policy and remanufacturing point to a lasting change in sourcing.

Key Takeaways: Australia Hospital Supplies Market

Hospital Activity Anchors Long-Term Demand

Revenue is on course to expand by about 66% across the decade, from USD 3,150.00 million in 2025 to USD 5,229.59 million in 2035 at a 5.2% CAGR. Hospital spending above AUD 123 billion and new beds in Queensland, Victoria and Western Australia keep consumable use rising.

Intravenous Therapy and Day Surgery Lead Growth

Surgical and Procedural Disposables hold the largest share, but Syringes, Needles and IV Therapy grows at an estimated 6.0% CAGR and Day Surgery and Specialty Clinics at an estimated 6.4% CAGR through 2035. Baxter's March 2025 expansion and state elective surgery funding support both.

Healthscope Sale Reopens Private Hospital Supply Contracts

The planned transfer of Healthscope's remaining hospitals to four buyers is the largest ownership change in private hospital care in years, and supply agreements are likely to be reviewed as operations are integrated.

• Calvary leads a consortium taking 14 of the 25 remaining hospitals
• Completion is expected by 30 November 2026
• Receivers were appointed in May 2025

Australia Hospital Supplies Market Report Summary

Key Insight

Rising hospital activity, record state health budgets and a push for sovereign supply keep demand for disposables, protective equipment and infusion products firm. New South Wales leads; Queensland grows fastest.

Key Trends in the Australia Hospital Supplies Market

The Australia hospital supplies market is being reshaped by rising hospital spending, record state budgets, private hospital ownership change and closer scrutiny of procurement.

October 2026 - Australian Institute of Health and Welfare Reports Hospital Spending Above AUD 123 Billion

• The Australian Institute of Health and Welfare said in October 2026 that hospital spending topped AUD 123 billion, with growth outpacing primary health care and prevention.
• Faster growth in hospital spending than in community care keeps procedural and acute-care consumables at the centre of demand.
• Suppliers of disposables benefit from this skew, though larger budgets will bring closer cost scrutiny from purchasers.

September 2026 - Healthscope's 25 Remaining Hospitals Set to Pass to Four Buyers

• The Urban Developer reported in late September 2026 that Calvary leads a consortium taking 14 of the 25 remaining Healthscope hospitals.
• Healthe Care takes six, Acurio Health three and KnG Group two, with completion expected by 30 November 2026.
• A change of owner may reopen supply contracts for gloves, drapes and intravenous consumables, favouring suppliers with national reach.

June 2026 - Queensland Funds AUD 35.5 Billion Health Budget and Hospital Rescue Plan

• Queensland Health said on 23 June 2026 that its budget provides AUD 35.5 billion, including a fully funded Hospital Rescue Plan.
• The plan adds hospitals at Toowoomba, Coomera and Bundaberg and expands 10 existing hospitals, with more than 2,600 additional beds.
• AUD 247 million for 25,000 more elective surgeries lifts demand for surgical disposables, gloves and intravenous products.

June 2025 - Victorian Auditor-General Finds Weak Tracking of Off-Contract Hospital Spending

• The audit, tabled on 19 June 2025, found HealthShare Victoria cannot show the savings that its collective agreements actually deliver.
• A pilot found about AUD 3 million of possible off-contract leakage across 24 agreements, including gloves, needles and syringes, though the figure is likely overstated.
• Tighter contract compliance favours suppliers already on statewide panels.

Key Insight

Larger hospital budgets, private hospital ownership change and closer scrutiny of off-contract buying are the main structural forces, while cost pressure on public purchasers is the main risk.

Recent Market Developments in the Australia Hospital Supplies Market

Recent developments, presented from the most recent, show glove and surgical product demand at Ansell, a sharper medical technology focus at BD, device remanufacturing at Cardinal Health and sovereign fluid supply at Baxter.

August 2026 - Ansell Reports Higher Sales and Earnings on Surgical and Cleanroom Demand

• Ansell reported on 24 August 2026 sales of USD 2,140.2 million, up 6.8%, and adjusted EBIT of USD 321.9 million, up 14.1%.
• Its healthcare segment grew sales and earnings on demand for cleanroom and surgical products, according to The Motley Fool Australia.
• It targets adjusted earnings per share of US158 to US170 cents for the following year, backed by volumes and pricing actions.

February 2026 - BD Completes Waters Combination and Becomes a Pure-Play Medical Technology Company

• On 9 February 2026 BD completed the combination of its biosciences and diagnostic solutions business with Waters and received USD 4 billion in cash.
• BD now reports four segments: medical essentials, connected care, biopharma systems and interventional.
• The sharper focus should concentrate investment on hospital-facing products sold to Australian public and private hospitals.

January 2026 - Cardinal Health Recruits for Beresfield Remanufacturing Site

• The Newcastle Herald reported on 26 January 2026 that Cardinal Health was recruiting for its first Australian site dedicated to remanufacturing single-use medical devices.
• The Beresfield site will start with compression sleeves used in post-surgical care and deep vein thrombosis prevention.
• Devices return to use after quality testing and high-level disinfection, diverting waste from landfill.

March 2025 - Baxter Expansion at Toongabbie Backed by AUD 20 Million of Federal Funding

• Health Minister Mark Butler announced on 5 March 2025 a AUD 40 million expansion, split equally between Baxter and the Commonwealth.
• Capacity rises to 80 million units a year, against national demand of about 60 million units, with some export potential to New Zealand.
• The investment is expected to secure about 1,500 jobs at the western Sydney site.

Key Insight

Strong glove demand, remanufacturing of single-use devices, a sharper medical technology focus and sovereign fluid capacity show suppliers positioning for resilience and sustainability across the forecast period.

Australia Hospital Supplies Industry Segmentation

The Expert Market Research’s report on the Australia Hospital Supplies Market offers a detailed analysis of the market based on the following segments.

Market Breakup by Product Type

• Surgical and Procedural Disposables
• Personal Protective Equipment
• Syringes, Needles and IV Therapy
• Wound Care and Dressings
• Infection Prevention and Sterilisation Supplies
• Others

Surgical and Procedural Disposables lead on value, in our estimate, because drapes, gowns, packs and catheters are used in every procedure, and Queensland funded 25,000 more elective surgeries in June 2026. Syringes, Needles and IV Therapy grows fastest at an estimated 6.0% CAGR through 2035, backed by Baxter's March 2025 expansion to 80 million units of fluid capacity. Personal Protective Equipment is supported by Ansell's higher healthcare sales reported in August 2026. Wound Care and Dressings follows an ageing patient base, while Infection Prevention and Sterilisation Supplies tracks procedure volumes. Others cover specimen collection and diagnostic consumables.

Market Breakup by End User

• Public Hospitals
• Private Hospitals
• Day Surgery and Specialty Clinics
• Others

Public Hospitals lead, in our estimate, as Victoria allocated AUD 1.6 billion in May 2026 so every public hospital has the funding it needs, and New South Wales funded 2,900 additional planned surgeries a year in June 2026. Private Hospitals face ownership change as Calvary, Healthe Care, Acurio Health and KnG Group take over Healthscope sites by November 2026. Day Surgery and Specialty Clinics grows fastest at an estimated 6.4% CAGR through 2035 as elective surgery programs scale up. Others include rehabilitation, aged care and community providers.

Market Breakup by Procurement Channel

• Government Group Purchasing Contracts
• Distributors and Wholesalers
• Direct Manufacturer Sales
• Online and E-Procurement Platforms
• Others

Government Group Purchasing Contracts lead, in our estimate, because the Victorian auditor-general reported in June 2025 that HealthShare Victoria ran 72 collective agreements covering 1,086 supplier agreements. Distributors and Wholesalers serve hospitals outside statewide panels and smaller private operators. Direct Manufacturer Sales grows fastest at an estimated 5.8% CAGR through 2035 as hospitals seek supply resilience, shown by Baxter's March 2025 sovereign supply expansion and Cardinal Health's January 2026 Beresfield remanufacturing site. Online and E-Procurement Platforms grows from a small base as purchasers tighten off-contract spending.

Market Breakup by Region

• New South Wales
• Victoria
• Queensland
• Western Australia
• Others

New South Wales dominates, in our estimate, as the state with the largest population and hospital network, and its June 2026 budget adds AUD 10.3 billion for health over four years, so it grows at an estimated 4.8% CAGR through 2035 from a large base. Queensland is the fastest-growing region at an estimated 6.2%, on its June 2026 Hospital Rescue Plan and 2,600 new beds. Victoria grows at 5.0% on a AUD 32.3 billion health budget. Western Australia grows at 5.7%, with 118 beds at Mount Lawley Hospital from September 2026. Others, covering the remaining states and territories, grow at 4.9% from smaller hospital networks.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Competitive Landscape in the Australia Hospital Supplies Market

Competition combines global medical technology groups, glove and protective equipment makers, domestic manufacturers and specialist distributors. Entry barriers include Therapeutic Goods Administration approval, panel positions on statewide supply agreements, local warehousing and the ability to guarantee supply during global disruptions.

Ansell

Ansell, headquartered in Richmond, Melbourne, makes examination and surgical gloves and protective products, which it sells to hospitals through its healthcare segment. On 24 August 2026 it reported sales of USD 2,140.2 million, up 6.8%, with healthcare sales and earnings rising on cleanroom and surgical product demand. It targets adjusted earnings per share of US158 to US170 cents for the following year, supported by volumes and pricing.

Cardinal Health

Cardinal Health, headquartered in Dublin, Ohio, supplies medical products to hospitals in Australia through its local business. The Newcastle Herald reported in January 2026 that it was recruiting for Beresfield, its first Australian site dedicated to remanufacturing single-use medical devices. The site starts with compression sleeves for post-surgical care and deep vein thrombosis prevention, returning devices to use after testing and high-level disinfection.

BD

BD, headquartered in Franklin Lakes, New Jersey, sells medication delivery, infusion and other hospital products worldwide, including to Australian hospitals. On 9 February 2026 it completed the combination of its biosciences and diagnostic solutions business with Waters and received USD 4 billion in cash. It now describes itself as a pure-play medical technology company with four segments, including medical essentials and connected care.

Baxter

Baxter, headquartered in Deerfield, Illinois, produces intravenous fluids at its Toongabbie plant in western Sydney. On 5 March 2025 the federal health minister announced a AUD 40 million expansion, funded equally by Baxter and the Commonwealth, lifting capacity to 80 million units a year from 2027 against national demand of about 60 million units. The investment is expected to secure about 1,500 jobs at the site.

Other players operating in the Australia hospital supplies market include Medline, B. Braun, Molnlycke Health Care, Device Technologies, and Smith+Nephew, alongside regional distributors, domestic manufacturers, sterile processing suppliers and private-label packagers supplying public and private hospitals, day surgery centres and clinics across Australia.

Key Insight

Competition rests on panel positions in statewide supply agreements, supply security, local manufacturing and regulatory approval rather than price alone, while hospital ownership changes could reshape buyer relationships.